Literature DB >> 19720636

A BEAUTIFUL lesson--ivabradine protects from ischaemia, but not from heart failure: through heart rate reduction or more?

Gerd Heusch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19720636     DOI： 10.1093/eurheartj/ehp360

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  11 in total

Review 1.  Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure.

Authors:  Peter J Schwartz; Gaetano M De Ferrari
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

2.  Pleiotropic, heart rate-independent cardioprotection by ivabradine.

Authors:  P Kleinbongard; N Gedik; P Witting; B Freedman; N Klöcker; G Heusch
Journal:  Br J Pharmacol       Date:  2015-07-21       Impact factor: 8.739

Review 3.  Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.

Authors:  Gerd Heusch; Petra Kleinbongard
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

4.  Medium-Term Outcomes in COVID-19.

Authors:  Zaki Akhtar; Sumeet Sharma; Ahmed I Elbatran; Lisa W M Leung; Christos Kontogiannis; Michael Spartalis; Alice Roberts; Abhay Bajpai; Zia Zuberi; Mark M Gallagher
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

5.  Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.

Authors:  Ercole Tagliamonte; Teresa Cirillo; Fausto Rigo; Costantino Astarita; Antonino Coppola; Carlo Romano; Nicola Capuano
Journal:  Adv Ther       Date:  2015-08-21       Impact factor: 3.845

6.  Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillation.

Authors:  Jordi Heijman; Gerd Heusch; Dobromir Dobrev
Journal:  Clin Med Insights Cardiol       Date:  2013-08-11

Review 7.  Risk-benefit assessment of ivabradine in the treatment of chronic heart failure.

Authors:  Irmina Urbanek; Krzysztof Kaczmarek; Iwona Cygankiewicz; Pawel Ptaszynski
Journal:  Drug Healthc Patient Saf       Date:  2014-04-28

8.  Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction.

Authors:  Daniel M O'Connor; Robert S Smith; Bryan A Piras; Ronald J Beyers; Dan Lin; John A Hossack; Brent A French
Journal:  J Am Heart Assoc       Date:  2016-04-22       Impact factor: 5.501

9.  A low resting heart rate at diagnosis predicts favourable long-term outcome in pulmonary arterial and chronic thromboembolic pulmonary hypertension. A prospective observational study.

Authors:  Florian F Hildenbrand; Ivan Fauchère; Lars C Huber; Stephan Keusch; Rudolf Speich; Silvia Ulrich
Journal:  Respir Res       Date:  2012-09-03

Review 10.  Ivabradine, coronary artery disease, and heart failure: beyond rhythm control.

Authors:  Pietro Scicchitano; Francesca Cortese; Gabriella Ricci; Santa Carbonara; Michele Moncelli; Massimo Iacoviello; Annagrazia Cecere; Michele Gesualdo; Annapaola Zito; Pasquale Caldarola; Domenico Scrutinio; Rocco Lagioia; Graziano Riccioni; Marco Matteo Ciccone
Journal:  Drug Des Devel Ther       Date:  2014-06-03       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.